Registered entities
Tempest Therapeutics, Inc.
Reg. No. 45-1472564United States
Innovation
12 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,250 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 1 |
Investor mix
9 investors on record; lead investors include F-Prime Capital, Versant Ventures, Quan Capital; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 78% |
| Private equity | 1 | 11% |
| Other / undisclosed | 1 | 11% |